Works matching IS 2160763X AND DT 2019 AND VI 8 AND IP 1
Results: 16
Distribution, Metabolism, and Excretion of Gedatolisib in Healthy Male Volunteers After a Single Intravenous Infusion.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 22, doi. 10.1002/cpdd.615
- By:
- Publication type:
- Article
Ketoconazole and Liver Injury: A Five‐Year Update.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 6, doi. 10.1002/cpdd.652
- By:
- Publication type:
- Article
A Randomized, Open‐Label, Crossover Phase 1 Study to Evaluate the Effects of Food on the Pharmacokinetics of a Single Oral Dose of a 15‐mg Tylerdipine Tablet in Healthy Chinese Male Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 126, doi. 10.1002/cpdd.622
- By:
- Publication type:
- Article
Evaluation of the Safety, Tolerability, and Pharmacokinetics of GSK2269557 (Nemiralisib) Administered Via Dry Powder Inhaler to Healthy Japanese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 78, doi. 10.1002/cpdd.614
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 1, doi. 10.1002/cpdd.589
- Publication type:
- Article
Clinical Pharmacokinetics and Drug‐Drug Interaction Potential for Coadministered SCY‐078, an Oral Fungicidal Glucan Synthase Inhibitor, and Tacrolimus.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 60, doi. 10.1002/cpdd.588
- By:
- Publication type:
- Article
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 70, doi. 10.1002/cpdd.576
- By:
- Publication type:
- Article
Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 107, doi. 10.1002/cpdd.575
- By:
- Publication type:
- Article
Tramadol Hydrochloride at Steady State Lacks Clinically Relevant QTc Interval Increases in Healthy Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 95, doi. 10.1002/cpdd.473
- By:
- Publication type:
- Article
Bioequivalence Evaluation of Two Oral Formulations of Acetaminophen in Healthy Subjects: Results From a Randomized, Single‐Blind, Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 9, doi. 10.1002/cpdd.469
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacodynamic Correlations From 2 Studies Evaluating Abuse Potential of Hydrocodone Extended‐Release Tablets.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 32, doi. 10.1002/cpdd.468
- By:
- Publication type:
- Article
Open‐Label, Dose‐Escalation, Phase 1 Study of Safety and Single and Multiple‐Dose Pharmacokinetics of Dichlorphenamide in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 87, doi. 10.1002/cpdd.464
- By:
- Publication type:
- Article
Does Dapagliflozin Affect Energy Intake and Appetite? A Randomized, Controlled Exploratory Study in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 119, doi. 10.1002/cpdd.461
- By:
- Publication type:
- Article
Comparative Pharmacokinetics and Pharmacodynamics of Bococizumab Following a Single Subcutaneous Injection Using Drug Substance Manufactured at Two Sites or Administration via Two Different Devices.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 40, doi. 10.1002/cpdd.454
- By:
- Publication type:
- Article
Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 16, doi. 10.1002/cpdd.445
- By:
- Publication type:
- Article
A Thorough QT/QTc Study With Laquinimod, a Novel Immunomodulator in Development for Multiple Sclerosis and Huntington Disease.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 1, p. 49, doi. 10.1002/cpdd.442
- By:
- Publication type:
- Article